ID

31079

Description

Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00517790

Link

https://clinicaltrials.gov/show/NCT00517790

Keywords

Versions (1)
  1. 7/19/18 7/19/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 19, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Small Cell Lung Cancer (NSCLC) NCT00517790

English

Eligibility Non-Small Cell Lung Cancer (NSCLC) NCT00517790

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject must be histologically or cytologically diagnosed with advanced or metastatic nsclc
Description

Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer metastatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278987
subjects must have at least one lesion measurable by ct scan as defined by recist
Description

Measurable lesion Quantity CT scan

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0040405
the measurable lesion may have not received radiation therapy
Description

Therapeutic radiology procedure Absent Measurable lesion

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C1513041
subject has an eastern cooperative oncology group (ecog) performance status of 0-2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
subject has received at least one prior line of systemic treatment but no more than two treatment regimen(s) for advanced or metastatic nsclc. in addition, the subject may have received systemic neo-adjuvant or adjuvant chemotherapy for nsclc
Description

Line Systemic therapy Quantity | Therapeutic procedure Quantity Non-Small Cell Lung Carcinoma Advanced | Therapeutic procedure Quantity Non-small cell lung cancer metastatic | Chemotherapy Neoadjuvant Systemic Non-Small Cell Lung Carcinoma | Adjuvant Chemotherapy Systemic Non-Small Cell Lung Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C4524693
UMLS CUI [1,2]
C1515119
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0007131
UMLS CUI [2,4]
C0205179
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0278987
UMLS CUI [4,1]
C0392920
UMLS CUI [4,2]
C0600558
UMLS CUI [4,3]
C0205373
UMLS CUI [4,4]
C0007131
UMLS CUI [5,1]
C0085533
UMLS CUI [5,2]
C0205373
UMLS CUI [5,3]
C0007131
adequate organ function
Description

Organ function

Data type

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject has received targeted vegf/pdgf tki (tyrosine kinase inhibitor) therapy. prior avastin is allowed.
Description

VEGFR Tyrosine Kinase Inhibitor Targeted Therapy | PDGF Tyrosine kinase inhibitor Targeted Therapy | Avastin allowed

Data type

boolean

Alias
UMLS CUI [1,1]
C2985521
UMLS CUI [1,2]
C2985566
UMLS CUI [2,1]
C0032200
UMLS CUI [2,2]
C1268567
UMLS CUI [2,3]
C2985566
UMLS CUI [3,1]
C1135130
UMLS CUI [3,2]
C0683607
subject has untreated brain or meningeal metastases.
Description

Metastatic malignant neoplasm to brain untreated | Meningeal Carcinomatosis untreated

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0220654
UMLS CUI [2,2]
C0332155
history of greater than 10% weight loss
Description

Weight decreased Percentage

Data type

boolean

Alias
UMLS CUI [1,1]
C1262477
UMLS CUI [1,2]
C0439165
subject has clinically relevant hemoptysis
Description

Hemoptysis

Data type

boolean

Alias
UMLS CUI [1]
C0019079
the subject has proteinuria ctc grade > 1
Description

Proteinuria CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0033687
UMLS CUI [1,2]
C1516728
the subject currently exhibits symptomatic or persistent, uncontrolled hypertension defined as diastolic blood pressure > 100 mmhg or systolic blood pressure > 150 mmhg. subjects may be re-screened if blood pressure is shown to be controlled with or without intervention.
Description

Uncontrolled hypertension Symptomatic | Uncontrolled hypertension Persistent | Diastolic blood pressure | Systolic Pressure | Control of blood pressure Associated with Intervention | Control of blood pressure Without Intervention

Data type

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C0205322
UMLS CUI [3]
C0428883
UMLS CUI [4]
C0871470
UMLS CUI [5,1]
C1753303
UMLS CUI [5,2]
C0332281
UMLS CUI [5,3]
C0184661
UMLS CUI [6,1]
C1753303
UMLS CUI [6,2]
C0332288
UMLS CUI [6,3]
C0184661
the subject has a documented left ventricular ejection fraction < 50%
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
Back to the top of the page

Similar models

Eligibility Non-Small Cell Lung Cancer (NSCLC) NCT00517790

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer metastatic
Item
subject must be histologically or cytologically diagnosed with advanced or metastatic nsclc
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278987 (UMLS CUI [2])
Measurable lesion Quantity CT scan
Item
subjects must have at least one lesion measurable by ct scan as defined by recist
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
Therapeutic radiology procedure Absent Measurable lesion
Item
the measurable lesion may have not received radiation therapy
boolean
C1522449 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1513041 (UMLS CUI [1,3])
ECOG performance status
Item
subject has an eastern cooperative oncology group (ecog) performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Line Systemic therapy Quantity | Therapeutic procedure Quantity Non-Small Cell Lung Carcinoma Advanced | Therapeutic procedure Quantity Non-small cell lung cancer metastatic | Chemotherapy Neoadjuvant Systemic Non-Small Cell Lung Carcinoma | Adjuvant Chemotherapy Systemic Non-Small Cell Lung Carcinoma
Item
subject has received at least one prior line of systemic treatment but no more than two treatment regimen(s) for advanced or metastatic nsclc. in addition, the subject may have received systemic neo-adjuvant or adjuvant chemotherapy for nsclc
boolean
C4524693 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0007131 (UMLS CUI [2,3])
C0205179 (UMLS CUI [2,4])
C0087111 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0278987 (UMLS CUI [3,3])
C0392920 (UMLS CUI [4,1])
C0600558 (UMLS CUI [4,2])
C0205373 (UMLS CUI [4,3])
C0007131 (UMLS CUI [4,4])
C0085533 (UMLS CUI [5,1])
C0205373 (UMLS CUI [5,2])
C0007131 (UMLS CUI [5,3])
Organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
VEGFR Tyrosine Kinase Inhibitor Targeted Therapy | PDGF Tyrosine kinase inhibitor Targeted Therapy | Avastin allowed
Item
subject has received targeted vegf/pdgf tki (tyrosine kinase inhibitor) therapy. prior avastin is allowed.
boolean
C2985521 (UMLS CUI [1,1])
C2985566 (UMLS CUI [1,2])
C0032200 (UMLS CUI [2,1])
C1268567 (UMLS CUI [2,2])
C2985566 (UMLS CUI [2,3])
C1135130 (UMLS CUI [3,1])
C0683607 (UMLS CUI [3,2])
Metastatic malignant neoplasm to brain untreated | Meningeal Carcinomatosis untreated
Item
subject has untreated brain or meningeal metastases.
boolean
C0220650 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0220654 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Weight decreased Percentage
Item
history of greater than 10% weight loss
boolean
C1262477 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
Hemoptysis
Item
subject has clinically relevant hemoptysis
boolean
C0019079 (UMLS CUI [1])
Proteinuria CTCAE Grades
Item
the subject has proteinuria ctc grade > 1
boolean
C0033687 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Uncontrolled hypertension Symptomatic | Uncontrolled hypertension Persistent | Diastolic blood pressure | Systolic Pressure | Control of blood pressure Associated with Intervention | Control of blood pressure Without Intervention
Item
the subject currently exhibits symptomatic or persistent, uncontrolled hypertension defined as diastolic blood pressure > 100 mmhg or systolic blood pressure > 150 mmhg. subjects may be re-screened if blood pressure is shown to be controlled with or without intervention.
boolean
C1868885 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2,1])
C0205322 (UMLS CUI [2,2])
C0428883 (UMLS CUI [3])
C0871470 (UMLS CUI [4])
C1753303 (UMLS CUI [5,1])
C0332281 (UMLS CUI [5,2])
C0184661 (UMLS CUI [5,3])
C1753303 (UMLS CUI [6,1])
C0332288 (UMLS CUI [6,2])
C0184661 (UMLS CUI [6,3])
Left ventricular ejection fraction
Item
the subject has a documented left ventricular ejection fraction < 50%
boolean
C0428772 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial